Efficacy and safety of vunakizumab in moderate-to-severe chronic plaque psoriasis: A randomized, double-blind, placebo-controlled phase 3 trialKexiang Yan, Jinhua Xu, Zhenghua Zhang et al.|Journal of the American Academy of Dermatology|2024Cited by 28
Efficacy and Safety of TLL-018 in Moderate to Severe Chronic Spontaneous Urticaria Patients with Inadequate Response to H1 Antihistamine: Results from a Phase Ⅰb StudyQianjin Lu, Peiyu Sun, Bin Yang et al.|Journal of Allergy and Clinical Immunology|2024Cited by 8